Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Tarsons Products
NSEI:TARSONS Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
Tarsons Products
Popular
Undervalued
Overvalued
Tarsons Products
AN
Analyst Price Target
Consensus Narrative from 5 Analysts
Automation And New Products Will Create Future Opportunities
Key Takeaways The ramp-up of the Panchla facility and focus on automation are set to enhance production capacity, improve operating margins, and drive profitability. Expansion into international markets and new product lines in healthcare could significantly increase revenue growth and broaden the customer base.
View narrative
₹597.40
FV
44.5% undervalued
intrinsic discount
14.93%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
TARSONS
Tarsons Products
Your Fair Value
₹
Current Price
₹331.35
1.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
7b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹7.2b
Earnings ₹558.6m
Advanced
Set as Fair Value